BCM-599
BCM-599 is a HBV (hepatitis B virus) capsid assembly inhibitor with the activity of inhibiting HBV capsid assembly. BCM-599 showed an IC50 value of 0.88μM and a CC50 value of 144μM in HepG2.2.15 cells. When used in combination with lamivudine, BCM-599 showed a synergistic inhibitory effect on viral concentration. BCM-599 can be used as an effective combined inhibition option for HBV infection.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1820763-99-2
- Formel: C14H10Cl2FN3O2
- Molecular Weight:342.15
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 2.2.15 | CC50 |
144 μM
Compound: 36; BCM-599
|
Cytotoxicity against human HepG2(2.2.15) cells after 24 hrs by MTS assay
Cytotoxicity against human HepG2(2.2.15) cells after 24 hrs by MTS assay
|
[PMID: 28383274] |
Chemical Information
-
CAS. Nr. 1820763-99-2
-
Molecular Weight 342.15
-
Formel C14H10Cl2FN3O2
-
SMILES
FC1=CC=C(C=C1)C(NCC(NC2=C(N=C(C=C2)Cl)Cl)=O)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)